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Abstract
Purpose: The purpose of the study was to evaluate the
role of intravoxel incoherent motion (IVIM) diffusion
model for the assessment of liver fibrosis and inflamma-
tion in diffuse liver disorders, also considering the
presence of liver steatosis and iron deposits.
Methods: Seventy-four patients were included, with liver
biopsy and a 3 Tesla abdominal magnetic resonance
imaging examination, with an IVIM diffusion-weighted
sequence (single-shot spin-echo echo-planar sequence,
with gradient reversal fat suppression; 6 b-values: 0, 50,
200, 400, 600, and 800 s/mm2). Histological evaluation
comprised the Ishak modified scale, for grading inflam-
mation and fibrosis, plus steatosis and iron loading
classification. The liver apparent diffusion coefficient
(ADC) and IVIM parameters (D, D*, f) were calculated
from the IVIM images. The relationship between IVIM
parameters and histopathological scores were evaluated
by ANOVA and Spearman correlation tests. A test–
retest experiment assessed reproducibility and repeata-
bility in 10 healthy volunteers and 10 randomly selected
patient studies.
Results: ADC and f values were lower with higher
fibrosis stages (p = 0.009, p = 0.006, respectively) and
also with higher necro-inflammatory activity grades
(p = 0.02, p = 0.017, respectively). Considered to-
gether, only fibrosis presented a significant effect on
ADC and f measurements (p < 0.05), whereas inflam-
mation had no significant effect (p > 0.05). A mild
correlation was found between ADC and f with fibrosis
(RS = -0.32 and RS = -0.38; p < 0.05) and inflam-
mation (RS = -0.31 and RS = -0.32, p < 0.05;
respectively). The AUROC for ADC and fmeasurements
with the different dichotomizations between fibrosis or
inflammation grades were only fair (0.670 to 0.749,
p < 0.05). Neither D nor D* values were significantly
different between liver fibrosis or inflammation grades.
D measurements were significantly different across his-
tologic grades of steatosis (p < 0.001) and iron overload
(p < 0.001), whereas f measurements showed significant
differences across histologic steatosis grades (p = 0.005).
There was an excellent agreement between the different
readers for ADC, f, and D.Correspondence to: Manuela Franc¸a; email: mariamanuela.franca@
gmail.com
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Conclusions: Although fibrosis presented a significant
effect on ADC and f, IVIM measurements are not
accurate enough to stage liver fibrosis or necro-inflam-
matory activity in diffuse liver diseases. D values were
influenced by steatosis and iron overload.
Key words: Magnetic resonance—Diffusion-weighted
imaging—Intravoxel incoherent motion—Liver
ﬁbrosis—Liver steatosis—Iron overload
Diffuse liver diseases are related to a wide spectrum of
etiologies, such as viral hepatitis infection, alcohol and
drug consumption, fatty liver, auto-immune and meta-
bolic diseases, leading to longstanding liver damage and
inﬂammatory reaction, and ﬁnally triggering ﬁbrosis
with extracellular sinusoidal accumulation of collagens,
proteoglycans and macromolecules. Patients with liver
inﬂammation and ﬁbrosis may remain asymptomatic,
being important to promptly and reliably detect and
grade both conditions to start treatment early enough [1].
Although liver biopsy is still considered the gold stan-
dard for the evaluation of liver fibrosis and inflamma-
tion, its use is declining, as the technique is invasive and
might not be safe for the patient [2]. Furthermore, biopsy
has accuracy limitations related to the large sampling
bias and high inter- and intra-observer variability reports
[3]. Consequently, there is a need to evaluate noninvasive
biomarkers for diagnosing and staging the whole liver
inflammatory injury and fibrosis status.
Diffusion-weighted (DW) magnetic resonance (MR)
imaging has been proposed as a tool to assess liver
inﬂammation and ﬁbrosis [4–9]. Apparent diffusion
coefficient (ADC), derived from the monoexponential
fitting model, is heavily influenced by the b-value choice
and it is influenced not only by the diffusion of water in
the extracellular space but also by the capillary blood
perfusion [10]. The bi-exponential intravoxel incoherent
motion (IVIM) DW model [11, 12] allows separating the
diffusion and perfusion effects by quantifying the pure
diffusion coefficient (D), the pseudo-diffusion (D*), and
vascular fraction (f) microperfusion parameters. Lower
ADC values in liver with fibrosis were associated to both
liver compartment restrictions [13–16]. Other authors
found lower ADC values in fibrotic livers being only
dependent on perfusion parameters changes [5, 17, 18].
Liver inﬂammation is characterized by different
grades of hepatocytes’ swelling and necrosis, inﬂamma-
tory cells migration through liver sinusoids and increased
regional blood ﬂow [19]. Inflammatory responses may
also influence ADC measurements [6, 7, 9, 20–22] and
both diffusion and perfusion IVIM parameters.
The presence of concomitant fat and iron deposits in
the liver parenchyma might also affect water diffusion
and the derived biomarkers [23–27]. Moreover, the DW
sequence, performed with an echo-planar imaging tech-
nique, is prone to susceptibility artifacts induced by iron
deposits [23]. The possible interaction and confounding
effects of liver inflammation, fibrosis, fat and iron de-
posits in the IVIM parameters have not been previously
addressed in diffuse liver diseases.
Our objective was to evaluate the diagnostic accuracy
of IVIM parameters for the detection and staging of both
liver ﬁbrosis and inﬂammation, considering the different
clinical scenarios of diffuse liver disorders, and taking into
consideration the effects of steatosis and iron overload.
Patients and methods
Study design and population
The Institutional Review Board approved this prospec-
tive, comparative, non-randomized single center study.
Between April 2013 and January 2014, all adult pa-
tients referred for liver biopsy were invited to participate
in this study, except those with contra-indications to MR
examination. Over these 10 months, 88 patients were
recruited after obtaining written informed consent from
them. Since severe iron overload lowers the liver signal
intensity on MR images, patients with known
hemochromatosis were excluded (n = 8). Six patients
were afterwards excluded due to MR imaging movement
artifacts (n = 3), malignancy within the biopsy sample
(n = 2) and claustrophobia (n = 1). The final series
included 74 patients (Fig. 1).
To check for MR reproducibility and repeatability, 10
healthy volunteers with no liver disease were also col-
lected and evaluated with the same MR sequences.
Liver biopsy
One percutaneous biopsy sample per patient was ob-
tained under ultrasound guidance, using 16–18G needles.
Patients with focal liver lesions and suspected of having
diffuse liver disease underwent a second targeted biopsy
for the lesion. Although most biopsies were sampled
from the right anterior segments, the Couinaud seg-
mentation was registered to locate the regions of interest
(ROIs) at the MR images. In cases of patients that
underwent liver biopsy after the MR examination (10
patients), the liver biopsy was performed blinded to MR
evaluation and the MR imaging analysis and ROI mea-
surements were performed after biopsy.
Histological evaluation
Histological evaluation of biopsy samples was considered
the reference standard for the prospective assessment and
grading of liver inﬂammation and ﬁbrosis, steatosis and
iron deposits.
One pathologist (SG, 9 years’ experience), blinded to
the MR results, veriﬁed the quality of the specimens and
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evaluated the liver samples using hematoxylin-eosin,
Masson’s trichrome, and Perls’ Prussian stains. The
Ishak modiﬁed scale was used for grading inﬂammation
(0–18) and ﬁbrosis (F0–F6) [28]. Hepatic steatosis was
estimated according to the proportion of hepatocytes
containing fat vesicles: no steatosis (grade 0, less than
5%); mild steatosis (grade 1, 5% to 33%); moderate
steatosis (grade 2, 33% to 66%); and severe steatosis
(grade 3, more than 66%) [29]. Iron loading was scored
using a five grading system (0: no iron overload to 4:
severe overload) [30].
MR imaging examination
Mean time interval between biopsy and MR examination
was 2 days (range 0–25 days), most patients (77%) being
examined in the same day of liver biopsy.
MR scans were performed in a 3 Tesla system (3T-TX
Achieva, Philips Healthcare, The Netherlands), with a
sixteen-channel phased-array coil. The liver MR imaging
protocol included transverse T2-weighted turbo spin-echo
sequence (TR/TE 850/80 ms, matrix 560, ﬁeld of view
400 9 285 9 260 mm, slice thickness 5 mm, number of
slices 35), coronal transverse T2-weighted turbo spin-echo
sequence (TR/TE 1170/80 ms, matrix 448, ﬁeld of view
375 9 448 9 158 mm, slice thickness 4 mm, number of
slices 35), 2D multiecho chemical shift encoded gradient
echo sequence (12 echoes, TE’s = 0.99–8.69, echo spac-
ing = 0.7 ms; TR = 10 ms; ﬂip angle 10; voxel dimen-
sions, 3 9 3 mm; slice thickness, 7 mm; 0.3 mm gap; ﬁeld
of view, 375 9 302 mm, single breath-hold acquisition)
and transverse IVIM DW imaging sequence. IVIM
imagingwasperformedusing a single-shot spin-echo echo-
planar sequence (SE-EPI), with gradient reversal fat sup-
pression, using 6 b-values (0, 50, 200, 400, 600, and 800 s/
mm2) tomaximize information in a reasonable time frame,
and the following parameters: TR/TE 2205/74 ms, echo-
planar imaging factor 63, FOV 375 9 305 9 207 mm,
slice thickness 7 mm, matrix 256, receiver bandwidth
2000 Hz per pixel, number of slices 27, number of signals
averaged 2, parallel imaging (accelerating factor 2) and
respiratory-triggered acquisition. The scan duration was
about 10 min.
Image analysis
Images were exported as raw data to calculate liver
apparent diffusion coefﬁcient (ADC) and IVIM param-
eters using QUIBIM research analysis platform (Valen-
cia, Spain). Images from the different b-values were
spatially registered using b = 0 as the reference. The
ADC was calculated by a monoexponential fitting using
all of b-values. The pure D and perfusion-related D* and
f parameters were obtained using the biexponential fit-
ting [12].
One radiologist (MF, 8 years’ experience) reviewed
the images blinded to the histological results and clinical
status. Three ROIs, 5 mm diameter, were manually
placed in the right lobe and within the biopsied liver
segment. ROIs were drawn in b-value = 0 and the
coordinates of the voxels within the ROI were used to
extract the values from the parametric maps. Care was
taken to avoid blood vessels, focal lesions, motion arti-
facts, regions with poor signal to noise and biopsy tracts.
For each ROI, the analysis was performed voxelwise and
all the histogram was considered, the average of the three
ROIs’ values being used for statistical analysis as the
dependent MR derived variables.
Reproducibility and repeatability tests
A test–retest experiment was designed to assess repro-
ducibility and repeatability. Ten healthy volunteers (4
men, 6 women; mean age 33 years) were scanned with the
same MR protocol as the patients. The MR examina-
Fig. 1. Study protocol flow
chart.
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tions were performed on two separate occasions, within
different sessions at the same day. Three blinded ob-
servers (MF, radiologist with 8 years’ experience; JO,
radiologist in the forth training year; JA, radiologist in
the second training year) separately and independently
evaluated the acquired images, placing 4 different ROIs
in the right liver lobe.
In order to further assess intra-observer repro-
ducibility, 10 randomly selected patients, with different
grades of ﬁbrosis and inﬂammatory activity, were as-
sessed by re-reading the studies on a second separate
occasion, by the same observer (MF).
Statistical analysis
Descriptive statistics were used to summarize the pa-
tients’ characteristics. Categorical variables were evalu-
ated by v2 and Fisher’s exact test. For statistical analysis,
necro-inflammatory activity score was grouped as none
(score 0), mild (scores 1–6), moderate (scores 7–12), and
severe inflammation (scores 13–18). The Ishak fibrosis
staging was categorized into none (F0), mild to moderate
fibrosis (F1–F3), and marked fibrosis/cirrhosis (F4–F6).
Steatosis was grouped as none (grade 0), mild (grade 1)
and significant steatosis (grade 2–3). Iron grades were
categorized as none (grade 0), mild (grade 1), and mod-
erated to severe siderosis (grade 2–4).
Differences in ADC, D, D*, and f measurements
across the categorical histologic grades of liver inflam-
mation, fibrosis, steatosis or iron deposits were assessed
with one-way analysis of variance, with post hoc Tukey
HSD test. The Kruskal–Wallis test, with post hoc Mann–
Whitney test and Bonferroni correction, was used when
the variances were non-homogeneous, as was the case of
f values across different grades of steatosis. Factorial
analysis of variance was performed to evaluate the joint
effect of fibrosis and inflammation. The Spearman cor-
relation coefficient was used to calculate the degree of
association between continuous and/or ordinal variables.
Receiver operating characteristic (ROC) analysis evalu-
ated the measurements’ diagnostic performance. The
area under the ROC curve (AUROC) was calculated for
each set of dichotomized groups of histological grades of
fibrosis (F0 vs. F1 or higher; F0–F3 vs. F4–F6) and
necro-inflammatory activity (grade 0 vs. 1 or higher;
grade 6 or lower vs. 7 or higher).
For measurements in volunteers, the agreement be-
tween the readers was assessed by intra-class correlation
coefﬁcients (ICCs) with 95% conﬁdence intervals for the
average values on each acquisition. Repeatability was
evaluated between the ﬁrst and second acquisitions in
volunteers.
SPSS (version 22; SPSS, IBM, Chicago, Ill) was used
for analysis. For all tests, a two-tailed p value of less than
0.05 was considered statistically significant.
Results
There were 74 patients in the ﬁnal study population,
including 38 men and 36 women, with a mean age of
46.4 years (standard deviation, 14.0; range of
19–77 years). The clinical indications for liver core biop-
sies were varied, including liver graft dysfunction
(n = 23), persistent elevation of liver enzymes (n = 17),
chronic HCV infection (n = 11), chronic alcoholic liver
disease (n = 5), chronic HBV infection (n = 5), assess-
ment of liver parenchyma during investigation of primary
malignant focal liver lesion (n = 3), auto-immune hep-
atitis (n = 3), non-alcoholic fatty liver disease (n = 3),
Wilson disease (n = 3), and toxic hepatitis (n = 1).
Histological results
All patients had adequate size biopsies (more than 15 mm
in size). The stages of ﬁbrosis and grades of necro-in-
ﬂammatory activity, steatosis, and siderosis observed on
histological analysis are summarized in Table 1.
Only 4 patients (5%) did not have liver ﬁbrosis or
necro-inﬂammatory activity. None of the patients had
severe liver inﬂammation. Twenty-eight (37.8%) patients
had neither liver steatosis nor iron overload, while 46
(62.2%) patients had both fat and iron liver deposition
within the sample. The grades of steatosis and siderosis,
the stage of ﬁbrosis, and the score of necro-inﬂammatory
activity were not signiﬁcantly associated (Fisher’s exact
test, p > 0.05).
Liver ADC and IVIM measurements
The ADC, D, D*, and fmeasurements are summarized in
Table 2. These biomarkers are shown accordingly to the
Table 1. Histological characteristics of patient population (n = 74
patients)
Characteristic Number (%)
Steatosis
0 50 (67.6)
1 14(18.9)
2 8 (10.8)
3 2 (2.7)
Iron
0 39 (52.7)
1 21 (28.4)
2 11 (14.9)
3 2 (2.7)
4 1 (1.4)
ISHAK necro-inflammatory activity
None (0) 6 (8.1)
Mild (1–6) 55 (74.3)
Moderate (7–12) 13 (17.6)
Severe (13–18) 0 (0)
ISHAK fibrosis grade
None or minimal (F0–F1) 17 (23.0)
Moderate (F2–F3) 45 (60.8)
Marked fibrosis/cirrhosis (F4–F6) 12 (16.2)
M. Franc¸a et al.: Evaluation of fibrosis and inflammation in diffuse liver 471
hepatic fibrosis stage and necro-inflammatory activity,
and also to the steatosis and siderosis grades.
Liver ﬁbrosis and inﬂammation
ADC and f values showed significant differences
(p = 0.009, p = 0.006, respectively) across fibrosis
stages (Fig. 2; Table 2): increasing stages of fibrosis
showed lower ADC (RS = -0.32, p < 0.05) and f val-
ues (RS = -0.38, p < 0.05). Using Tukey HSD test,
ADC and f measurements were only significantly dif-
ferent between patients with severe fibrosis or cirrhosis
(F4–F6) and patients without fibrosis (F0) (p < 0.05).
Calculated ADC and f values were also different
across histologic grades of liver inflammation (p = 0.02
and p = 0.017, respectively) (Fig. 3; Table 2). Using
post hoc analysis, the ADC and f values were only sig-
nificantly different between patients with moderate
inflammation and patients without inflammation
(p < 0.05), but were not significantly different between
patients with none or mild inflammation (p > 0.05).
ADC and f measurements had weak correlations with
liver necro-inflammatory activity grading (RS = -0.31,
p < 0.05; RS = -0.32, p < 0.05; respectively).
Neither the D nor the D* values were significantly
different across groups of liver fibrosis or inflammation
(p > 0.05).
Since the ADC and f measurements were both af-
fected by liver fibrosis and inflammation, we evaluated
their joint effect with Factorial Analysis of Variance
(dependent variable: ADC and IVIM parameters; fac-
tors: histological categorical variables—inflammation
and fibrosis). The interaction effect between inflamma-
tion and fibrosis was not significant (p = 0.748); thus, it
was removed from the univariate model. Considering the
main effects of both inflammation and fibrosis, fibrosis
presented a significant effect on ADC (p = 0.032) and
f measurements (p = 0.031), whereas inflammation had
no significant effect neither on ADC (p = 0.124) nor
f measurements (p = 0.137) (Fig. 4).
The accuracy of ADC or f measurements to discrimi-
nate the different stages of fibrosis or the necro-inflam-
matory activity grades was only fair. To distinguish
between patients without fibrosis (F0) from patients with
fibrosis (F1 or higher), the AUROC for ADC and f mea-
surements were 0.670 and 0.740 (p < 0.05), respectively.
To distinguish between patients without or mild fibrosis
(F0–F3) from patients with severe fibrosis and cirrhosis
(F4–F6), the AUROC for ADC and f values were 0.705
and 0.690 (p < 0.05), respectively. To differentiate pa-
tients without inflammation (score 0) from patients with
necro-inflammatory activity (score 1 or higher), the
AUROC for ADC and f values were 0.748 and 0.749
(p < 0.05), respectively. To distinguish patientswith none
or minor (scores 0–6) from moderate inflammatory
activity (scores 7–12), the AUROC for ADC and f values
were 0.682 and 0.687 (p < 0.05), respectively.
Hepatic steatosis and siderosis
Calculated D measurements were significantly different
across the histologic grades of steatosis (p < 0.001) and
iron overload (p < 0.001), whereas f measurements
showed significant differences only across histologic
steatosis grades (Kruskal–Wallis, p = 0.005) (Fig. 5).
Patients with increased fat deposition showed lower
D values (RS = -0.44, p < 0.001) and higher f values
(RS = 0.42, p < 0.001). However, the mean f value of
grade 1 steatosis group (0.37) was higher than grade 0
group (0.30) and grade 2 group (0.35) (Table 2).
Table 2. The ADC, D, D*, and f measurements are summarized according to the histological hepatic fibrosis stage and necro-inflammatory activity,
steatosis and siderosis grades
ADC (910-3mm2/s) D (910-3mm2/s) D* (910-3mm2/s) f (fraction)
Study population average 1.62 (0.38) 1.52, 1.38–1.81 0.68 (0.22) 0.75, 0.56–0.82 67.99 (22.26) 70.13, 50.59–83.16 0.32 (0.08) 0.32, 0.26–0.37
Fibrosis
F0 1.83 (0.45) 1.71, 1.45–2.15 0.66 (0.19) 0.70, 0.55–0.80 62.16 (18.67) 68.24, 46.89–74.41 0.37 (0.08) 0.36, 0.33–0.40
F1–F3 1.59 (0.34) 1.52, 1.38–1.79 0.68 (0.23) 0.76, 0.50–0.85 70.19 (23.46) 71.40, 51.92–86.38 0.31 (0.08) 0.31, 0.26–0.35
F4–F6 1.41 (0.26) 1.37, 1.21–1.65 0.70 (0.21) 0.76, 0.60–0.82 67.96 (22.48) 71.04, 49.63–84.97 0.28 (0.05) 0.28, 0.22–0.33
Necro-inflammatory activity
0 1.94 (0.49) 1.85, 1.50–2.32 0.59 (0.14) 0.57, 0.45–0.73 75.62 (13.32) 75.36, 61.74–90.09 0.39 (0.09) 0.39, 0.31–0.46
1–6 1.63 (0.38) 1.52, 1.40–1.84 0.67 (0.23) 0.76, 0.54–0.84 69.62 (21.19) 71.83, 51.20–85.86 0.32 (0.08) 0.33, 0.26–0.37
7–12 1.43 (0.19) 1.46, 1.28–1.56 0.73 (0.18) 0.76, 0.61–0.86 57.54 (27.54) 57.45, 33.94–71.93 0.28 (0.05) 0.29, 0.25–0.32
Steatosis
0 (<5%) 1.60 (0.39) 1.49, 1.35–1.81 0.73 (0.19) 0.78, 0.64–0.86 67.24 (23.94) 70.81, 46.51–83.16 0.30 (0.08) 0.28, 0.25–0.33
1 (6% to 33%) 1.78 (0.41) 1.74, 1.60–1.92 0.60 (0.22) 0.66, 0.43–0.80 70.13 (16.85) 70.40, 53.41–86.91 0.37 (0.07) 0.36, 0.32–0.43
2 (>33%) 1.47 (0.41) 1.45, 1.33–1.52 0.47 (0.15) 0.45, 0.33–0.60 68.72 (22.79) 65.22, 48.32–81.32 0.35 (0.02) 0.34, 0.33–0.36
Iron deposits
0 1.63 (0.38) 1.53, .140–1.82 0.75 (0.18) 0.77, 0.63–0.86 63.73 (22.54) 68.03, 44.97–79.80 0.31 (0.08) 0.30, 0.26–0.34
1 1.61 (0.32) 1.52, 1.42–1.70 0.69 (0.17) 0.76, 0.57–0.80 69.28 (18.24) 70.45, 52.57–83.78 0.32 (0.06) 0.33, 0.27–0.37
2–4 1.58 (0.48) 1.46, 1.27–1.86 0.47 (0.25) 0.39, 0.27–0.76 77.91 (24.91) 76.34, 64.78–89.92 0.35 (9.10) 0.36, 0.31–0.41
Group data are presented as mean (standard deviation), median and interquartile range
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The D values were negatively correlated with iron
overload (RS = -0.36, p = 0.002).
There were no signiﬁcant differences on the ADC and
D* values among histologic grades of liver steatosis or
siderosis (p > 0.05).
Unfortunately, the number of patients in this study
did not allow a multivariate analysis to test for all the
interactions between the different categorical histologic
variables in ADC or IVIM measurements.
Reproducibility of DW measurements
The median, IQR for ADC and IVIM values of healthy
volunteers are presented in Table 3. Agreement was
considered as poor (ICC, 0–0.50), fair to good (ICC,
0.50–0.80), very good (ICC > 0.80) or excellent
(ICC, > 0.90).
Regarding the test–retest examination of 10 volun-
teers, there was an excellent agreement between the dif-
ferent readers for the measurements of ADC, D and f,
and a fair agreement for the D* measurements. The
reproducibility between the two different MR examina-
tions was good for the ADC measurements (ICC > 0.8,
p < 0.05) and excellent for the D and f estimated values
(ICC > 0.86, p < 0.05). However, for the D* measure-
ments, there was no agreement between measurements
from the two different examinations (p > 0.05).
The intra-reader variability in the 10 patients was
assessed by the ICCs between measurements performed
Fig. 2. Box and whisker plots of ADC (A) and perfusion
fraction (f) (B) measured in all patients, compared with his-
tological fibrosis staging. A There was a negative correlation
in ADC values with increasing Ishak fibsosis stage (RS =
-0.32, p < 0.05). B There was a negative correlation in
perfusion fraction (f) with increasing Ishak fibsosis stage
(RS = -0.38, p < 0.05).
Fig. 3. Box and whisker plots of ADC (A) and perfusion
fraction (f) values (B) measured in all patients, compared with
histologic necro-inflammatory activity grading. A There was a
negative correlation in ADC values with increasing Ishak necro-
inflammatory grading (RS = -0.31, p < 0.05). B There was a
negative correlation in perfusion fraction with increasing Ishak
necro-inflammatory grading (RS = -0.32, p < 0.05).
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on two different occasions. The intra-reader ICC on
volunteers was excellent (ICC > 0.91, p < 0.05) for the
ADC and all IVIM measurements. Furthermore, the
intra-reader ICC in 10 patients was excellent for all of the
MR measurements (ICC > 0.92, p < 0.001).
Discussion
We report that ADC and f values were lower with higher
fibrosis stages, in patients with diffuse liver diseases.
However, the correlation between these MR measure-
ments and fibrosis stages was weak and the accuracy of
ADC or f measurements to discriminate the different
stages of fibrosis or the necro-inflammatory activity
grades was only fair.
Several studies have associated reduced liver ADC
measurements with liver ﬁbrosis and cirrhosis [4, 6–9, 13,
17, 20–22, 31, 32]. ADC measurements contain both
diffusion and perfusion components, which difficult the
biological interpretation of reduced ADC values. The
IVIM model allows separating the liver signal intensity
changes due to true molecular diffusion from those re-
lated to perfusion within the tissue. Recently, it has been
proposed that the IVIM model, and particularly the
perfusion-related parameters D* and f, would be more
advantageous to evaluate liver fibrosis than conventional
ADC measurements [5, 13–18, 33–35]. However, the
influence of liver inflammation, steatosis and siderosis on
liver values has to be considered in this analysis.
Initial studies showed that D* values measurements
were lower in patients with cirrhosis than in non-cir-
rhotic patients [5]. However, other studies observed
lower D, D* and f values in patients with cirrhosis
compared to non-cirrhotic patients [33], and lower f and
D* values in patients with severe fibrosis (METAVIR
‡F3) [17]. Lower D, D*, and f values were observed with
increasing stages of liver fibrosis in patients studied at 1.5
Fig. 5. Box and whisker plots of perfusion fraction (f) values
measured in all patients, compared with histologic grading of
liver steatosis (percentage of hepatocytes with cytoplasmatic
lipid vacuoles). Higher perfusion fraction was observed in
patients with increased fat deposition (RS = 0.42, p < 0.001).
Fig. 4. Box and whisker plots of ADC (A) and perfusion
fraction (f) values (B) measured in all patients, compared with
histologic fibrosis staging and grouped by necro-inflammatory
activity grading. Considering the main effects of both inflam-
mation and fibrosis, fibrosis presented a significant effect on
ADC (p = 0.032) and f measurements (p = 0.031), with lower
ADC in higher stages of liver fibrosis, whereas inflammation
had no significant effect neither on ADC (p = 0.124) nor
f measurements (p = 0.137).
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and 3 Tesla magnets [13, 14]. Three different animal
studies reported contradictory results. Chow et al. [16]
observed lower D and D* values with increasing liver
fibrosis. Zhang et al. [18] observed that f values decreased
with increasing fibrosis stage; however, they did not as-
sess D* parameter. Finally, Hu et al. [15] observed in-
verse correlations between fibrosis stages and D, D*, and
f measurements. Unluckily, none of these animal studies
evaluated the influence of necro-inflammatory activity,
fat or iron on IVIM parameters.
Our ﬁndings of diminished ADC and f values with
increasing fibrosis support the previously reported per-
fusion-related association. As ADC measurements con-
tain both diffusion and perfusion components, the
different results for ADC and D values might be ex-
plained by changes in the liver perfusion rather than pure
diffusion of water molecules restriction. These findings
most probably reflect the accumulation of collagen de-
posits, which increases the hepatic resistance to portal
blood flow and reduces the portal perfusion within the
liver.
Inﬂammatory changes, such as cell necrosis and
inﬂammatory cell inﬁltration within the sinusoids, might
also inﬂuence DW signal. It has been reported that ADC
and f values decreased not only with fibrosis stage [4–9,
13, 17, 20–22, 31–33] but also with the severity of necro-
inflammatory activity [6, 7, 9, 20–22]. However, in our
series, only fibrosis was the main explicative variable for
the ADC and perfusion-related f decrements.
Although we found differences across grades of
inﬂammation and ﬁbrosis with ADC and f measure-
ments, only a mild correlation was discovered between
the histological grades and MR measurements. More-
over, the AUROC that evaluate dichotomized fibrosis
stages or inflammatory grades were fair, under 0.8. Thus,
neither the ADC nor the f measurements demonstrated
adequate accuracy to discriminate between different
stages of liver fibrosis or grades of inflammatory activity.
Therefore, the observed differences do not allow for an
appropriate staging of fibrosis and inflammation
pathological markers.
Imaging biomarkers might also be inﬂuenced by
confounding factors such as fat or iron deposits, which
are frequently present in diffuse liver diseases. We ob-
served that pure D decreased with increasing grades of
steatosis, similar with previous reports [24, 27, 34, 35].
Steatosis decrease water molecules movement due to the
enlarged hepatocytes, overloaded with macrovesicles of
fat, restricting both intracellular and extracellular diffu-
sion [24]. Furthermore, the f measurements were influ-
enced by fat deposition, increasing with the grade of liver
steatosis. Steatosis may have a confounding effect in
f measurements. The mean f values of grade 1 steatosis
group (0.37) were higher than grade 0 (0.30) and grade 2
(0.35) groups, which might be explained by the effect of
fibrosis, inflammation and steatosis in f measurements.
Unfortunately, as previously mentioned, the number of
patients in this study did not allow a multivariate anal-
ysis to test for all the interactions between the different
categorical histologic variables in ADC or IVIM mea-
surements.
Only the D values were significantly reduced by iron
deposits, decreasing with the severity of overload. These
values decreased mainly due to the signal decay and noise
floor effects induced by the susceptibility effects of iron
overload [23, 36].
Regarding D* measurements, they were not related to
the stage of liver fibrosis or inflammation and, quite
important, they were not consistent between different
MR examinations in volunteers.
This study has some limitations. We used 6 different
b-values, a lower number than some previous studies.
Nevertheless, there is no consensus about the ideal
number of b-values that should be used and, moreover, it
has been demonstrated the feasibility of IVIM analysis of
DW images using a number of b-value as low as 4 [17,
37]. We have assessed test–retest reproducibility in vol-
unteers and not in patients with liver diseases; the ob-
tained results from normal tissue might not be
adequately extrapolated to diseased livers [38]. There
were relatively fewer patients with severe steatosis or
siderosis scores, and no patient with severe inflamma-
tion, which might have limited the statistical significance
of the results and have hampered the performance of
factorial analyses with all the variables together. Another
limiting factor is that the MR images and the histological
Table 3. MR measurements data on 10 volunteers, with the analysis of inter-examination, inter-reader and intra-reader variability
ADC (910-3mm2/s) D (910-3mm2/s) D* (910-3mm2/s) f
Average values in volunteersa 1.82, 1.53–2.27 0.73, 0.47–0.86 69.99, 63.41–77.16 0.36, 0.31–0.45
Inter-examination variabilityb
Observer 1 0.83 (0.32–0.96) 0.96 (0.86–0.99) -0.06 (-5.53–0.76) 0.93 (0.75–0.98)
Observer 2 0.87 (0.51–0.97) 0.92 (0.68–0.98) -1.38 (-7.83–0.42) 0.86 (0.48–0.96)
Observer 3 0.91 (0.64–0.98) 0.96 (0.86–0.99) 0.55 (-0.66–0.89) 0.94 (0.70–0.98)
Inter-observer variabilityb
Time 1 0.95 (0.86–0.99) 0.99 (0.97–1.00) 0.77 (0.36–0.94) 0.98 (0.93–0.99)
Time 2 0.93 (0.80–0.98) 0.97 (0.93–0.99) 0.70 (0.21–0.92) 0.95 (0.86–0.99)
Intra-reader variability (10 patients)b 0.94 (0.63–0.99) 0.98 (0.93–1.00) 0.93 (0.75–0.98) 0.92 (0.70–0.98)
a Median, IQR
b ICC (95% confidence interval)
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results were analyzed by only one reader and, therefore,
variability of both these results could not be assessed.
ROIs were drawn in the same liver segment than liver
biopsy to minimize the effect of the heterogeneously
distributed diffuse liver damage. As most MR examina-
tions were performed after liver biopsy, care was taken to
avoid the biopsy tract although unrecognized hemor-
rhage or edema might have influenced MR results. Also,
Ishak score is not a continuous scale and the increase of
fibrous tissue accumulation or necro-inflammatory
activity from one grade to another is not linear [39].
However, even with this limitations, liver biopsy is still
considered the best reference standard. Although larger
scale studies should validate the relationship between
ADC and IVIM parameters and different degrees of
fibrosis and inflammation, to definitively evaluate the
interactions of different histologic variables on IVIM
parameters, we believe that after our study the role of
IVIM is limited in routine clinical practice and patient’s
outcome evaluation.
In conclusion, in spite of the differences in ADC and
f derived IVIM values across different groups of liver
fibrosis and inflammation, these metrics cannot properly
discriminate between different stages of fibrosis or
inflammation in different diffuse liver diseases. Steatosis
may confound the f measurements. D* and D parameters
are not useful biomarkers of liver fibrosis: D* is not a
reproducible measure and D measurements are influ-
enced by confounders such as fat and iron, which com-
monly coexist with liver fibrosis.
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